Suza Nur

Suza Nur is a Postdoctoral Scholar affiliated with the Cao Lab, focusing on interdisciplinary research at the intersection of epigenetics, molecular biology, and computational biology. Her work explores mechanisms underlying cancer progression, immune response modulation, and drug discovery through advanced in silico methods. Key research areas include epigenetic regulation of cancer pathways, natural compound-based therapies, and antiviral drug design targeting pathogens like SARS-CoV-2 and MERS-CoV. Nur’s studies also integrate metabolomics and environmental biotechnology, such as wastewater treatment innovations using membrane bioreactors.

Her research interests span from understanding DNA methylation dynamics in cancer cells to designing multiepitope vaccines and identifying bioactive compounds from plant sources (e.g., Catharanthus roseus, Avicennia marina) for therapeutic applications. She employs computational tools for drug discovery, including molecular docking and siRNA design, alongside experimental validation of epigenetic编辑编辑编辑编辑编辑编辑 editing strategies to enhance cancer immunotherapy.

Nur’s articles reflect a strong focus on translational research, bridging basic science and clinical applications. Her work often addresses unmet needs in oncology, infectious diseases, and environmental health, with contributions to both mechanistic understanding and practical solutions. While no formal awards or grants are listed, her prolific publication record highlights sustained engagement with high-impact research topics.

Her affiliation with the Cao Lab suggests collaborative research within a team specializing in epigenetics and molecular medicine, though specific lab roles or funding sources are not detailed here.